One of the biggest blind spots in the COVID response wasn’t just droplets vs airborne.
It was the failure to act on asymptomatic / pre-symptomatic transmission even though evidence appeared right from January 202.
Thread 🧵 From the very start, scientists warned that people could spread SARS-CoV-2 before symptoms appeared.
If that’s true, symptom-based controls (find the sick person → isolate them) will always miss a large share of transmission.

By January 2020, UK IPC guidance sat with Public Health England under senior medical leadership from, Chief Medical Officer, Chris Whitty @CMO_England
They knew the airborne debate
They knew SARS-1
They knew healthcare transmission
Yet COVID was classified as droplet
Thread 👇 This wasn’t a blank slate.
The AGP framework already existed, built on the idea that only certain procedures generated aerosol risk.
That framework dictated protection.
Outside it, surgical masks were the norm.

Six years ago today, @WHO leadership publicly stated that COVID was airborne before that framing was immediately corrected to droplet transmission.
That moment shaped global transmission classification at the outset of the pandemic.
Thread 👇 WHO Director-General,Tedros Adhanom Ghebreyesus @DrTedros stated that COVID was airborne. Following an off-mic exchange & note from Executive Director Dr Michael Ryan, he then corrected this to droplet transmission.

Aerosol Generating Procedures (AGPs) are clinical interventions historically believed to be the only situations producing infectious aerosols triggering higher respiratory protection.
They became the cornerstone of respiratory IPC risk stratification. The rationale was procedural: disruptive airway interventions- intubation, suction, ventilation were assumed to generate aerosols in quantities capable of transmitting infection.
Routine respiratory activity was not considered comparable risk.

🧵 THREAD: The quiet revolution in aerosol transmission (2017–2019)
In the years just before COVID, scientists were increasingly clear that “droplet vs airborne” was a false binary and that real-world transmission didn’t fit it. Across epidemiology, virology, and aerosol science, researchers were synthesising evidence from influenza, SARS-1, measles, and TB that challenged droplet-based infection models.

🧵What infection control failed to integrate

Outside formal IPC guidance, between 2013-2016 scientists were uncovering how everyday human activity generates infectious aerosols in indoor spaces, a finding with direct consequences for hospital transmission. Using high-speed imaging, Lydia Bourouiba (MIT fluid dynamics) and colleagues showed that coughs, sneezes and speech produce turbulent gas clouds that generate fine aerosols capable of remaining suspended in shared air.
(JAMA 2014; NEJM 2016)

Aerosol transmission of SARS-CoV-1 was identified during the 2002–2003 SARS outbreak, including in hospital settings This was recognised during the outbreak itself, not years later, when transmission patterns could not be explained by droplets or close contact alone.

How do aerosol viruses like SARS-CoV-2 spread in hospital settings? 🧵
Understanding airborne transmission is essential to preventing hospital-acquired COVID. Aerosols are tiny particles released when people breathe, speak, cough, or shout.
Unlike droplets, aerosols can remain suspended in the air, travel beyond close contact, and accumulate indoors.